The prevalence of anxiety and depression in cardiac arrest survivors: A systematic review and meta-analysis

Xiaoli Chen,Dongze Li,Lin He,Wenjie Yang,Min Dai,Lin Lan,Dongmei Diao,Liqun Zou,Peng Yao,Yu Cao

DOI: https://doi.org/10.1016/j.genhosppsych.2023.03.013

IF: 7.587

2023-03-30

General Hospital Psychiatry

Abstract:Objective This systematic review aimed to identify the prevalence of anxiety and depression in cardiac arrest (CA) survivors. Methods A systematic review and network meta-analysis was performed on observational studies in adult cardiac arrest survivors with psychiatric disorders from PubMed, Embase, Cochrane Library and Web of Science. In the meta-analysis, we combined the prevalence quantitatively and analyzed the subgroup based on the classification indexes. Results We identified 32 articles that met the inclusion criteria. Regarding anxiety,the pooled prevalence was 24% (95% CI, 17–31%) and 22% (95% CI, 13–26%) in short-term and long-term respectively. The subgroup analysis showed that the pooled incidence in in-hospital cardiac arrest (IHCA) and out-of-hospital cardiac arrests (OHCA) survivors was 14.0% (95%CI, 9.0–20.0%) and 28.0% (95%CI, 20.0–36.0%) for short-term anxiety.The incidence of anxiety measured by, Hamilton Anxiety Rating Scale(HAM-A) and State-Trait Anxiety Inventory(STAI) was higher than other tools( P < 0.01). Regarding depression,the data analysis showed that the pooled incidence of short-term and long-term depression was 19% (95% CI, 13–26%) and 19% (95% CI, 16–25%), respectively. The subgroup analysis showed that the incidence of short-term and long-term depression was 8% (95% CI, 1–19%) and 30% (95% CI, 5–64%) for IHCA survivors, and was 18% (95% CI, 11–26%) and 17% (95% CI, 11–25%) for OHCA survivors. The incidence of depression measured by Hamilton Depression Rating Scale(HDRS) and Symptom check list-90(SCL-90) was higher than other assessment tools( P < 0.01). Conclusions The meta-analysis indicated a high prevalence of anxiety and depression in CA survivors, and those symptoms persisted 1 year or more after CA. Evaluation tool is an important factor affecting the measurement results.

psychiatry